The study is about the Pipeline™ Vantage Embolization Device, which is used to treat intracranial aneurysms. This is a condition where a blood vessel in the brain bulges and can cause serious problems if it bursts. The device helps to stop the aneurysm from growing by blocking blood flow to it. The study aims to check how safe and effective this device is after it was approved for use.

To join the study, you must be an adult, have signed consent, and have an aneurysm that can be treated with this device. You should not participate if you have health issues that could be worsened by the study, are pregnant or breastfeeding, or are in another study that could affect results.

• The study involves multiple centers and is a single-arm study, meaning everyone gets the same treatment.
• You must be able to attend follow-up visits as planned in the study.
• It's important to understand all risks and benefits before joining.